MYCOF (Mydecine Innovations Group) 10-Year Share Buyback Ratio : -159.30% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Mydecine Innovations Group 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Mydecine Innovations Group's current 10-Year Share Buyback Ratio was -159.30%.

MYCOF's 10-Year Share Buyback Ratio is ranked worse than
99.36% of 621 companies
in the Drug Manufacturers industry
Industry Median: -2.8 vs MYCOF: -159.30

Competitive Comparison of Mydecine Innovations Group's 10-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mydecine Innovations Group's 10-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's 10-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Mydecine Innovations Group 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Mydecine Innovations Group (OTCPK:MYCOF) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Mydecine Innovations Group 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (OTCPK:MYCOF) » Definitions » 10-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

0NF0:Germany MYCO:Canada

Address

1890 – 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.